Cardiovascular Effects of Racemic Epinephrine Pellets

Clinical trial NCT04688346 · COMPLETED

Trial details

NCT number: NCT04688346
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Epinephrine Causing Adverse Effects in Therapeutic Use

Start date: 2019-06-10
Primary completion: 2019-11-30
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.